miR-155 in cancer drug resistance and as target for miRNA-based therapeutics

MicroRNAs: Target Recognition and Regulatory Functions

Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068

A microRNA expression signature of human solid tumors defines cancer gene targets

Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697

Regulation of microRNA biogenesis

Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462

PD-1 and Its Ligands in Tolerance and Immunity

Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111

NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · cited 3×

Identification of tissue-specific microRNAs from mouse

Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00809-6 · Cited by 3,355

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023

Mangiferin: A natural bioactive immunomodulating glucosylxanthone with potential against cancer and rheumatoid arthritis

Akkewar, A. S., Mishra, K. A., & Sethi, K. K. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23765 · Cited by 14

MiRNAs in cancers and renin-angiotensin-aldosterone system: Implications for chemoradiotherapy resistance

Li, M., Wang, C., Liu, H., Xu, Z., & Liu, Y. (2025) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203251367136 · Cited by 16

The Functional Mechanism of MicroRNA in Oral Lichen Planus

Li, Y., He, Y., Xiang, J., Feng, L., Wang, Y., & Chen, R. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s369304 · Cited by 15

Screening the human miRNA interactome reveals coordinated up-regulation in melanoma, adding bidirectional regulation to miRNA networks

Jame-Chenarboo, F., Reyes, J. N., Twells, N. M., Ng, H. H., Macdonald, D., Hernando, E., & Mahal, L. K. (2025) · Science Advances · doi:10.1126/sciadv.adr0277 · Cited by 19

MicroRNA‑138 inhibits tumor growth and enhances chemosensitivity in human cervical cancer by targeting H2AX

Yuan, M., Zhao, S., Chen, R., Wang, G., Bie, Y., Wu, Q., & Cheng, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8238 · Cited by 15

Exosomal miRNAs: Key Regulators of the Tumor Microenvironment and Cancer Stem Cells

Wang, S., Jin, S. K., Zhang, J., & Wang, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199323 · Cited by 17

Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control

Taheriazam, A., Bayanzadeh, S. D., Farahani, M. H., Mojtabavi, S., Zandieh, M. A., Gholami, S., Heydargoy, M. H., Hondori, M. J., Kangarloo, Z., Behroozaghdam, M., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175781 · Cited by 14

The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers

Jafari, S., Motedayyen, H., Javadi, P., Jamali, K., Hasan‐Abad, A. M., Atapour, A., & Sarab, G. A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1355064 · Cited by 13

miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses

Toropko, M., Chuvpilo, S. A., & Karabelsky, A. V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16080986 · Cited by 14

Epstein-Barr Virus Latent Membrane Protein 1 Regulates Host B Cell MicroRNA-155 and Its Target FOXO3a via PI3K p110α Activation

Hatton, O. L., Smith, M. M., Alexander, M. T., Mandell, M., Sherman, C., Stesney, M. W., Hui, S. T., Dohrn, G., Medrano, J., Ringwalt, K., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02692 · Cited by 14

MicroRNA-155-5p promotes cell proliferation and invasion in lung squamous cell carcinoma through negative regulation of fibroblast growth factor 9 expression

Liu, F., Mao, Q., Zhu, S., & Qiu, J. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-882 · Cited by 14

Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma

Xiao, J., & Xiu-sheng, H. (2021) · Cancer Management and Research · doi:10.2147/cmar.s336265 · Cited by 14

LncRNA miR503HG Regulates the Drug Resistance of Recurrent Cervical Squamous Cell Carcinoma Cells by Regulating miR-155/Caspase-3

Zhao, S., Yu, M., & Wang, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s225489 · Cited by 14

Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance

Patutina, O., Chiglintseva, D., Bichenkova, E. V., Miroshnichenko, S. K., Mironova, N. L., Vlassov, V. V., & Аркадьевна, З. М. (2020) · Molecules · doi:10.3390/molecules25102459 · Cited by 13

Highly Stable and Integrable Graphene/Molybdenum Disulfide Heterojunction Field-Effect Transistor-Based miRNA Biosensor

Wang, C., Wang, Z., Gao, M. X., Zhu, Y., Zhu, H., Zhou, L., Zhou, Y., Tian, X., Liu, Y., Zhang, Y., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c03827 · Cited by 12

Long Noncoding RNA MMP2-AS1 Contributes to Progression of Renal Cell Carcinoma by Modulating miR-34c-5p/MMP2 Axis

Fan, B., Niu, Y., Ren, Z., Wei, S., Ma, Y., Su, J., & Zhang, A. (2022) · Journal of Oncology · doi:10.1155/2022/7346460 · Cited by 12

miR-876-3p suppresses the progression of colon cancer and correlates the prognosis of patients

Ma, H., Li, M., Jia, Z., Chen, X., & Bu, N. (2021) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2021.104682 · Cited by 12

MicroRNA-155-5p Contributes to 5-Fluorouracil Resistance Through Down-Regulating TP53INP1 in Oral Squamous Cell Carcinoma

Liu, B., Hu, J., Zhao, H., Zhao, L., & Pan, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.706095 · Cited by 13

Poly(ADP-ribose) polymerase-1 promotes expression of miR-155 by the up-regulation of methyl-CpG binding domain protein 2 in TK6 cells exposed to hydroquinone

Gui, Z., Zhang, H., Tan, Q., Ling, X., Liu, Z., Peng, J., Shao, J., Wu, M., Yuan, Q., Li, J., et al. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.11.007 · Cited by 12

JunD-miR494-CUL3 axis promotes radioresistance and metastasis by facilitating EMT and restraining PD-L1 degradation in esophageal squamous cell carcinoma

Li, X., Cong, J., Zhou, X., Gao, W., Li, W., Yang, Q., Li, X., Liu, Z., & Luo, A. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216731 · Cited by 11

Potential functions of hsa-miR-155-5p and core genes in chronic myeloid leukemia and emerging role in human cancer: A joint bioinformatics analysis

Soltani, I., Bahia, W., Farrah, A., Mahdhi, A., Ferchichi, S., & Almawi, W. Y. (2021) · Genomics · doi:10.1016/j.ygeno.2021.04.014 · Cited by 11

A Single Variant in Pri-miRNA-155 Associated with Susceptibility to Hereditary Breast Cancer Promotes Aggressiveness in Breast Cancer Cells

Landeros, N., González‐Hormazábal, P., Pérez-Moreno, P., Tapia, J. C., & Lilian Jara, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315418 · Cited by 11

Potential of natural products in the treatment of myocardial infarction: focus on molecular mechanisms

Sheida, A., Taghavi, T., Shafabakhsh, R., Ostadian, A., Bahabadi, Z. R., Mahabady, M. K., Hamblin, M. R., & Mirzaei, H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2020720 · Cited by 12

Potential therapeutic applications of microRNAs in cancer diagnosis and treatment: Sharpening a double-edged sword?

Rhman, M. A., & Owira, P. M. O. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175210 · Cited by 10

miR-137: a potential therapeutic target for lung cancer

Liu, S., Ruan, Y., Chen, X., Bao, H., & Chen, Q. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1427724 · Cited by 10

The diagnostic and predictive potential of lncRNA CASC2 targeting miR-155 in systemic lupus erythematosus patients with nephritis complication

Mohamed, N. A., El-Fattah, A. I. A., Shaker, O. G., & Sayed, G. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-81212-5 · Cited by 10

BNEMDI: A Novel MicroRNA–Drug Interaction Prediction Model Based on Multi-Source Information With a Large-Scale Biological Network

Guan, Y.-J., Yu, C.-Q., Li, L., You, Z., Ren, Z.-H., Pan, J., & Li, Y.-C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.919264 · Cited by 10

HDAC6 Negatively Regulates miR-155-5p Expression to Elicit Proliferation by Targeting RHEB in Microvascular Endothelial Cells under Mechanical Unloading

Xu, L., Zhang, L., Zhang, X., Li, G., Wang, Y., Dong, J., Wang, H., Hu, Z., Cao, X., Zhang, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910527 · Cited by 10

Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets

Tanigawa, K., Tomioka, Y., Misono, S., Asai, S., Kikkawa, N., Hagihara, Y., Suetsugu, T., Inoue, H., Mizuno, K., & Seki, N. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13681 · Cited by 10

Maximising efficacy in HER2-positive breast cancer: immunoliposomal co-delivery of miR155 inhibitor and paclitaxel for targeted therapy

Chaudhari, R. H., Patel, V., Malvi, B., Misra, S. K., & Kumar, A. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01090f · Cited by 9

MicroRNA155 in non-small cell lung cancer: a potential therapeutic target

Wei, X., Xiong, X., Chen, Z., Chen, B., Zhang, C.-T., & Zhang, W. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1517995 · Cited by 9

PD-L1/miR-155 Interplay in Pediatric High-Grade Glioma

Litak, J., Grajkowska, W., Bogucki, J., Kowalczyk, P., Petniak, A., Podkowiński, A., Szumiło, J., Kocki, J., Roliński, J., Rahnama, M., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12030324 · Cited by 9

miR‐450b promotes cell migration and invasion by inhibiting SERPINB2 in oral squamous cell carcinoma

Wang, X., Nie, X., Xu, G., Gao, J., Wang, B., Yang, J., & Song, G. (2022) · Oral Diseases · doi:10.1111/odi.14407 · Cited by 9

Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms

Nemours, S., Armesto, M., Arestin, M., Manini, C., Giustetto, D., Sperga, M., Pivovarčíková, K., Pérez‐Montiel, D., Hes, O., Michal, M., et al. (2024) · Pathology · doi:10.1016/j.pathol.2023.11.013 · Cited by 9

miRNA Biology in Chronic Lymphocytic Leukemia

Bayraktar, R., Fontana, B., Călin, G. A., & Németh, K. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.03.001 · Cited by 9

FAM225A promotes sorafenib resistance in hepatocarcinoma cells through modulating miR-130a-5p–CCNG1 interaction network

Liu, Y.-T., Liu, G.-Q., & Huang, J.-M. (2020) · Bioscience Reports · doi:10.1042/bsr20202054 · Cited by 9

MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development

Çetinkaya, M., & Baran, Y. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220803150431 · Cited by 9

MiR ‐4524b‐5p‐targeting ALDH1A3 attenuates the proliferation and radioresistance of glioblastoma via PI3K / AKT / mTOR signaling

Yu, H., Li, X., Li, Y., Wang, T., Wang, M., & Mao, P. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14396 · Cited by 9

Circ_0003489 facilitates multiple myeloma progression by targeting miR-433-3p/PBX3 axis

Yan, T., Wang, X., Zhou, D., Qiu, H., Zhang, J., & Yang, W. (2022) · Hematology · doi:10.1080/16078454.2022.2109554 · Cited by 8

MiR-342-5p protects neurons from cerebral ischemia induced-apoptosis through regulation of Akt/NF-κB pathways by targeting CCAR2

Zhu, H., Zhang, Y., & Zhu, Y. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106901 · Cited by 8

Aberrant stem cell and developmental programs in pediatric leukemia

Ling, R. E., Cross, J. W., & Roy, A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1372899 · Cited by 10

Weighted gene co‐expression network analysis to explore the mechanism of heroin addiction in human nucleus accumbens

Shi, X., Li, Y., Yan, P., Shi, Y., & Lai, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29422 · Cited by 8

Suppression of miR‑106a‑5p expression inhibits tumorigenesis via increasing CELF‑2 expression in spinal cord glioma

Xu, H., Wang, F., & Wang, L. (2021) · Oncology Letters · doi:10.3892/ol.2021.12888 · Cited by 8

MicroRNA-155 targets SOCS1 to inhibit osteoclast differentiation during orthodontic tooth movement

Yao, J., Mi, S., Li, X., Liu, Y., Han, N., Xu, J., Liu, Y., Li, S., & Guo, L. (2023) · BMC Oral Health · doi:10.1186/s12903-023-03443-8 · Cited by 7

miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas

Tili, E., Druck, T., Balatti, V., Michaille, J., Nuovo, G. J., & Croce, C. M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2422615122 · Cited by 7

miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response

Tili, E., Michaille, J., & Croce, C. M. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100088 · Cited by 7

The oncogenic role of miR-155 on oral cancer progression and treatment strategies

Aghiorghiesei, A. I., Mehterov, N. H., Nutu, A. M., Vladimirov, B., Nonchev, B., Kontos, C. K., Buduru, R., Braicu, C., & Berindan‐Neagoe, I. (2025) · Discover Oncology · doi:10.1007/s12672-025-03467-2 · Cited by 7

Micelleplex nucleic acid delivery systems: Overcoming barriers for treatment of advanced solid tumors

Doustmihan, A., Akbari, M., Jaymand, M., Liu, G., & Jahanban‐Esfahlan, R. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.115098 · Cited by 7

MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples

Foiani, G., Guelfi, G., & Mandara, M. T. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab057 · Cited by 7

Harnessing the LdCsm RNA Detection Platform for Efficient microRNA Detection

Yu, Z., Xu, J., & She, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032857 · Cited by 7

MiR‐548 K regulatory effect on the ABCG2 gene expression in MDR breast cancer cells

Saberiyan, M., Ghasemi, Z., & Yaghoobi, H. (2023) · Cancer Reports · doi:10.1002/cnr2.1816 · Cited by 7

Exosomal Delivery of miR-155 Inhibitor can Suppress Migration, Invasion, and Angiogenesis Via PTEN and DUSP14 in Triple-negative Breast Cancer

Razaviyan, J., Sirati‐Sabet, M., Hadavi, R., Karima, S., Bazl, M. R., & Mohammadi‐Yeganeh, S. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673341499241016110341 · Cited by 7

Expression level of miR-155, miR-15a and miR-19a in peripheral blood of ductal carcinoma breast cancer patients: Possible bioindicators for cellular inherent radiosensitivity

Rajabi, F., & Mozdarani, H. (2022) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2022.104758 · Cited by 7

MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets

Swearson, S., Rataan, A. O., Eliason, S. L., Amendt, B. A., Zakharia, Y., Salem, A. K., Ho, T. H., & Rustum, Y. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105604 · Cited by 7

Mulberry fruit repairs alcoholic liver injury by modulating lipid metabolism and the expression of miR-155 and PPARα in rats

Qiao, J., Li, H., Jinxiang, C., Shi, Y., Li, N., Zhu, P., Zhang, S., & Miao, M. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01131-y · Cited by 7

Propofol enhances the lethality of cisplatin on liver cancer cells by up-regulating miR-195-5p

Gao, L., & Zhang, X. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101680 · Cited by 7

Exosomal miRNA-based theranostics in cervical cancer: bridging diagnostics and therapy

Raghani, N. R., Chorawala, M. R., Parekh, K. P., Sharma, A., Alsaidan, O. A., Alam, P., Fareed, M., & Prajapati, B. G. (2025) · Medical Oncology · doi:10.1007/s12032-025-02752-y · Cited by 8

miR-34a-5p enhances the sensitivity of cervical cancer cells to oxaliplatin chemotherapy via targeting MDM4

He, P. T., Liu, X., Lou, Y., Gong, S., & Cao, L. (2022) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4902054 · Cited by 6

Valproic acid regulates the miR-155/Jarid2 axis by affecting miR-155 promoter methylation in glioma

Wang, R., Chen, Y., Kuang, W., Jiang, W., Zeng, W., Chen, Y., & Liu, Z. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023259 · Cited by 6

MicroRNA-376a-3p sensitizes CPT-11-resistant colorectal cancer by enhancing apoptosis and reversing the epithelial-to-mesenchymal transition (EMT) through the IGF1R/PI3K/AKT pathway

Jassi, C., Kuo, W., Chang, Y.-C., Wang, T., Ho, T., Hsieh, D. J., Kuo, C., Chen, M., Li, C., & Huang, C.-Y. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102125 · Cited by 6

Non-coding RNA-related antitumor mechanisms of marine-derived agents

Zhou, Z., Cao, Q., Diao, Y., Wang, Y., Long, L., Wang, S., & Li, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1053556 · Cited by 6

Downregulation of stromal syntenin sustains AML development

Leblanc, R., Ghossoub, R., Goubard, A., Castellano, R., Fares, J., Camoin, L., Audebert, S., Balzano, M., Bou‐Tayeh, B., Fauriat, C., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317570 · Cited by 6

Transcriptome analysis reveals that gga-miR-2954 inhibits the inflammatory response against Eimeria tenella infection

Yu, H., Tang, J., Dong, L., Tang, M., Arif, A., Zhang, T., Zhang, G., Xie, K., Zhao, Z., & Dai, G. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131807 · Cited by 5

Erianin as a Promising Novel Agent in the Treatment of Neuroblastoma: The Anticancer Effects and Underlying Molecular Mechanisms

Koçoğlu, S. S., Seçme, M., & Sunay, F. B. (2023) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520623666230228095429 · Cited by 5

A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease

Tao, R., Chen, J., Cheng, Y. S., Zhang, M., Mao, M., Xiang, R., Zuo, Z., Chang, J., Han, B., & Kang-hua, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0274277 · Cited by 5

Investigation of the regulation of EGF signaling by miRNAs, delving into the underlying mechanism and signaling pathways in cancer

Darmadi, D., Aminov, Z., Hjazi, A. M., Roopashree, R., Kazmi, S. W., Mustafa, Y. F., Hosseen, B., Sharma, A., Alubiady, M. H. S., & Al‐Abdeen, S. H. Z. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114267 · Cited by 5

MiR-526b-3p Inhibits the Resistance of Glioma Cells to Adriamycin by Targeting MAPRE1

Qiu, L., Xing, S., Lang, F., & Bao, Q. (2022) · Journal of Oncology · doi:10.1155/2022/2402212 · Cited by 5

The full recovery of mice (Mus Musculus C57BL/6 strain) from virus–induced sarcoma after treatment with a complex of DDMC delivery system and sncRNAs

Klimenko, O. V., & Sidorov, A. (2019) · Non-coding RNA Research · doi:10.1016/j.ncrna.2019.03.001 · Cited by 5

Trading places: Peptide and small molecule alternatives to oligonucleotide-based modulation of microRNA expression

Chaudhry, T., Coxon, C. R., & Ross, K. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.08.005 · Cited by 5

Molecular regulators of alcoholic liver disease: a comprehensive analysis of microRNAs and long non-coding RNAs

Zhang, L., Wang, R., Nan, Y., & Kong, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1482089 · Cited by 4

The role of small extracellular vesicles in ovarian cancer drug resistance: from bench clues to clinical implications

Chen, J., Gu, Z., Hua, K., Zhang, Y., Shen, F., Zhang, M., Zhou, G., & Ding, J. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02093-y · Cited by 4

Anti-miRNA- 155 - 5p enhances the cytotoxic efficacy of temozolomide in brain cancer stem cells

Özpak, L., Bağca, B. G., Avcı, Ç. B., Gündüz, C., & Durmaz, B. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04135-6 · Cited by 4

Delivery of Rna Drugs: Beyond the Liver, More than Vaccine

Elnaggar, M. G., He, Y., & Yeo, Y. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114203 · Cited by 4

miR-338-3p attenuates oxaliplatin resistance in gastric cancer cells via targeting thrombospondin-1

Lin, Y., Sun, D., Xu, Q., Li, Y., Sun, Y., Li, S., Cen, Y., & Sun, F. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.98039 · Cited by 4

Knockdown of LINC01138 protects human chondrocytes against IL‐1β‐induced damage by regulating the hsa‐miR‐1207‐5p/KIAA0101 axis

Zhang, J., & Lv, G. (2022) · Immunity Inflammation and Disease · doi:10.1002/iid3.744 · Cited by 4

Super enhancers as drivers of hallmarks of cancer: From oncogene activation to metastatic progression

Fan, S., Gao, Y., Dai, X., Ma, H., & Yang, Z. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104826 · Cited by 3

Oleanolic acid alleviates ovarian cancer by regulating the miR-122/PDK4 axis to induce autophagy and inhibit glycolysis in vivo and in vitro

Zeng, Z., Lin, Q., Yu, J., Lin, M. T., & Zhao, N. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1670758 · Cited by 3

Targeted RNA Degradation via LipoSM-RiboTAC Nanoparticles: A Versatile Platform for Cancer Therapy

Jiao, Z.-J., Song, C., Sha, X., Chen, Y., Xing, Y., Yang, F., Wang, R. Y., Ye, Y., Liu, Z., Tian, Z., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c04884 · Cited by 3

Spatiotemporal quantitative microRNA-155 imaging reports immune-mediated changes in a triple-negative breast cancer model

Skourti, E., Volpe, A., Lang, C., Johnson, P., Panagaki, F., & Fruhwirth, G. O. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1180233 · Cited by 3

The Regulatory Role of NcRNAs in Pyroptosis and Disease Pathogenesis

Wang, S., Chen, X., Wang, K., & Yang, S. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01720-7 · Cited by 3

Functional Roles of the lncRNA MALAT1 in Glioma

Moftakhar, A., Najafi, S., Anbiyaee, O., Farzaneh, M., & Khoshnam, S. E. (2023) · Current Cancer Therapy Reviews · doi:10.2174/1573394719666230720164009 · Cited by 3

Low‑dose ionizing radiation attenuates high glucose‑induced hepatic apoptosis and immune factor release via modulation of a miR‑155‑SOCS1 axis

Fan, H., Liu, S., Jiao, B., & Liang, X. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13058 · Cited by 3

Role of MicroRNA Modulated Wnt Pathway in Breast Cancer and Its Therapeutic Use

Banerjee, S., & Mandal, A. K. A. (2024) · Cytology and Genetics · doi:10.3103/s0095452724040108 · Cited by 3

Investigating the Therapeutic Effects of Naringenin and Oleuropein on Prostate Cancer Cell Mat-LyLu via miR-155-5p: A Bioinformatics and Molecular Docking Analysis of KRAS and CDK2 Networks

Güngörmez, Ç. (2026) · Genes · doi:10.3390/genes17010079 · Cited by 2

MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives

Pettorossi, F., Gasparotto, M., Ghirardello, A., Franco, C., Ceolotto, G., Giannella, A., Iaccarino, L., Zanatta, E., Doria, A., & Gatto, M. (2023) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000960 · Cited by 2

The role of miRNAs as biomarkers in cancer

Ou, Y., & Ren, Z. (2024) · Asia-Pacific Journal of Oncology · doi:10.32948/ajo.2024.10.18 · Cited by 2

ENTPD8 overexpression enhances anti-PD-L1 therapy in hepatocellular carcinoma via miR-214-5p inhibition

Zhao, S., Chen, M., Chen, F., Gao, Z., Li, X., Hu, L., Cheng, H. M., Xuan, J.-Y., Fei, J., & Song, Z.-W. (2025) · iScience · doi:10.1016/j.isci.2025.111819 · Cited by 2

Cannabinoids in Cancer: Cross-talk Between Cannabinoids and miRNAs

Salamat, J. M., Ledbetter, E. L., Abbott, K. L., Thungrat, K., Flannery, P. C., Huang, C. J., Ward, K. C., Dhanasekaran, M., & Pondugula, S. R. (2022) · Springer eBooks · doi:10.1007/978-981-16-8822-5_3 · Cited by 2

Expression and Clinical Values of Serum miR-155 and miR-224 in Chinese Patients with HCV Infection

Jin, X., Zhang, Y., Wang, H., & Zhang, Y. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s344345 · Cited by 2

LncRNA NEAT1 exacerbates non-small cell lung cancer by upregulating EIF4G2 via miR-582-5p sponging

Zhang, X., Sun, Z., & Zou, Y. (2020) · Archives of Biological Sciences · doi:10.2298/abs200218018z · Cited by 2

Functions and targets of miRNAs in pharmacological and toxicological effects of major components of Tripterygium wilfordii Hook F

Pan, W., Yang, B., He, D., Chen, L., & Fu, C. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02764-3 · Cited by 1

EZH2 ‐mediated downregulation of miR ‐155‐5p contributes to prostate cancer cell malignancy through SMAD2 and TAB2

Bai, Z., Liu, J., Xing, W., & Wang, H. (2025) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12936 · Cited by 1

Integrated in silico and experimental screening identifies novel ligands that target precursor microRNA-31 at the dicer cleavage site

Arhin, G., Haghpassand, L., & Keane, S. C. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00553a · Cited by 1

Functional dynamics of lncRNAs and miRNAs in cancer metabolism and neuroinflammation

Das, A., & Bhuiyan, A. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11964-y · Cited by 1

[Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior of Lung Squamous Cell Carcinoma H520 Cells].

Gou, L., He, Y., Qiu, P., & Huang, B. (2023) · PubMed Central · doi:10.3779/j.issn.1009-3419.2023.106.21 · Cited by 1

The SOX gene superfamily in oncogenesis: unraveling links to ncRNAs, key pathways, chemoresistance, and gene editing approaches

Ahmed, A. Y., Uthirapathy, S., Oghenemaro, E. F., Rekha, M. M., Kumawat, R., Mustafa, Y. F., Kariem, M., KADHIM, A. J., Sharma, S., & Kumar, M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04229-1 · Cited by 1

Effect of Down-Regulation of miR-23b-3p on the Differentiation of Acute Myeloid Leukemia via Wilms Cancer Gene 1

Cao, L., Zhang, J., Ren, H., & Han, Y. (2021) · Journal of Biomaterials and Tissue Engineering · doi:10.1166/jbt.2021.2696 · Cited by 1

Morphological profiling of all human and mouse miRNAs in 24M cellsPreprint

Wagner, J., Smillie, C. L., Sirey, T., Khamseh, A., Ponting, C. P., & Beentjes, S. V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.14.687149 · Cited by 1

Regulation of the long non-coding RNA FAM83H-AS1 by human papillomavirus in cervical cancer

Barr, J. A. (2019) · doi:10.33915/etd.3926

Expression and significance of miR-155 during embryo implantationPreprint

Lu, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1346128/v1

MicroRNA-155-5p in pathogenesis of cancer

Zborovskaya, I. B., & Komelkov, A. V. (2017) · Advances in molecular oncology · doi:10.17650/2313-805x-2017-4-3-27-36 · Cited by 4

miR-155 as a novel clinical target for hematological malignancies

Witten, L., & Slack, F. J. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz183 · Cited by 104

The Role of miR-155 in Antitumor Immunity

Kalkusova, K., Táborská, P., Stakheev, D., & Smrž, D. (2022) · Cancers · doi:10.3390/cancers14215414 · Cited by 76

MiR‐145 in cancer therapy resistance and sensitivity: A comprehensive review

Xu, W., Hua, Y.-T., Deng, F., Wang, D., Wu, Y. F., Zhang, W., & Tang, J. (2020) · Cancer Science · doi:10.1111/cas.14517 · Cited by 67

The multiple roles of microRNA-155 in oncogenesis

Higgs, G., & Slack, F. (2013) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-3-17 · Cited by 137